Lu-177-DOTAZOL
177Lu-DOTAZOL is a drug suitable for betatherapy of bone metastases [...]
Lu-177-TLX591
177Lu-TLX591 (177Lu-Rosopatamab, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled J591 [...]
Lu-177-ST2210 (IART – Lu-177 DOTA-Biotin)
IART® stands for Intraoperative Avidination for Radionuclide Treatment. It is [...]
Lu-177-PSMA-617 (Pluvicto™)
177Lu-PSMA-617 (177Lu-Vipivotide tetratexan) is a 177Lu labeled peptide developed [...]
Lu-177-Pentixather
177Lu-Pentixather is the therapeutic analogue of 68Ga-Pentixafor, to be used [...]
Lu-177-IPN-1072 (Lu-177-OPS201 – Lu-177-Satoreotide)
177Lu-IPN-1072 (177Lu-OPS201, 177Lu-DOTA-JR11, 177Lu-Satoreotide tetratexan) is the lutetium-177 analogue [...]
Lu-177-MVT-1075
177Lu-MVT-1075 is the therapeutic counterpart of 89Zr-DFO-HuMab-5B1 developed for the [...]
I-131-BA52
131I-BA52 is a small molecule, a melanin-binding benzamide, being developed [...]
I-131-TLX-101
TLX101 (formerly ACD-101) is a small molecule (4-Iodophenylalanine), radioactively labeled [...]
I-131-81C6 mAb (Neuradiab™)
131I-81C6 (131I-Monoclonal Antibody 81C6, Neuradiab™) is a radioimmunoconjugate consisting of [...]